Drug Eluting Stents Market by Top Key Players are Abbott, Boston Scientific Corporation, Biotronik, MicroPort Scientific Corporation, Medtronic, Terumo Corporation Forecast to 2026

The global drug eluting stent (DES) market size is forecast to reach USD 9.58 billion by 2026, attributable to the increasing prevalence of cardiovascular diseases worldwide. A drug eluting stent is a semi-rigid device in the form of a tube that is coated with a drug that helps to prevent restenosis of an arterial blockage when released. They help to reduce restenosis cases and also limits the risk of late or early thrombosis in patients. More information on the market is provided in a recently published report by Fortune Business Insights(TM) titled, "Drug Eluting Stent (DES) Market Size, Share & Industry Analysis, By Type (Coronary Stenting, and Peripheral Stenting), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol and Others), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026." As per this report, the market value was USD 5.71 billion in 2019 and will exhibit a CAGR of 6.6% between 2019 to 2026.

Highlights of the Report:

In-depth analysis of various insights, namely, Drug Eluting Stent Market trends, growth drivers, opportunities, and other related challenges.
Comprehensive details of key market players, their core competencies, and Drug Eluting Stent Market share.
The potency of suppliers and buyers to make better business decisions.
Lists out the market size in terms of volume.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/drug-eluting-stent-des-market-102612

Key Players Operating in The Drug Eluting Stent Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

Abbott
Boston Scientific Corporation
Biotronik
MicroPort Scientific Corporation
Medtronic
Terumo Corporation
Other Players
What is the Scope of the Report?

The report offers a 360-degree overview of the market and its prime growth trajectories such as drivers, restraints, challenges, and upcoming opportunities. It also discusses the market segment based on factors such as type, scaffold, drug, end-user, and regions. It also provides market figures and CAGRs of the leading segments with its attributed reasons. Additionally, the report throws light on current drug eluting stent market trends, key industry developments, and other interesting insights. Competitive landscape, list of players operating in the market and the strategies adopted by them to earn the leading position in the market are also listed in the report. For more information on the report, log on to the company website.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/drug-eluting-stent-des-market-102612

Regional Segmentation:

Rising Prevalence of Cardiovascular Diseases will Help Asia Pacific Witness Significant Growth

Currently, North America is holding the significant share drug eluting stent market share owing to the increasing prevalence of cardiovascular diseases and the supported reimbursement policies supported by governments in the region. In 2018, this region generated a revenue of USD 1.76 billion. Additionally, the increasing trend of biodegradable polymer-based drug eluting scaffolds may further help this region continue dominance in the forecast period as well. On the other side, the market in Europe will emerge as the fastest-growing region owing to the rise in the number of third-generation DES with the CE mark and the rising popularity of polymer technology for the production of stents. Furthermore, the increasing cases of cardiovascular diseases and the improving medical infrastructure and medical facilities will help Asia Pacific witness significant growth in the coming years.

Detailed Table of Content:

Introduction
1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

Executive Summary
Market Dynamics
3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

Key Insights
4.1. Prevalence of Cardiovascular Diseases, By Key Regions/ Key Countries, 2018

4.2. New Product Launches, By Key Market Players

4.3. Key Industry Developments, Such as Mergers & Acquisitions

4.4. Pricing Analysis, By Key Brands, Key Players/ Key Regions

Global Drug Eluting Stents (DES) Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary

5.2. Market Analysis, Insights and Forecast - By Type

5.2.1. Coronary Stenting

5.2.2. Peripheral Stenting

5.3. Market Analysis, Insights and Forecast - By Scaffold

5.3.1. Cobalt-Chromium

5.3.2. Platinum-Chromium

5.3.3. Nitinol

5.3.4. Others

5.4. Market Analysis, Insights and Forecast - By Drug

5.4.1. Sirolimus

5.4.2. Paclitaxel

5.4.3. Zotarolimus

5.4.4. Everolimus

5.4.5. Others

5.5. Market Analysis, Insights and Forecast - By End User

5.5.1. Hospitals

5.5.2. Specialty Clinics

5.6. Market Analysis, Insights and Forecast - By Region

5.6.1. North America

5.6.2. Europe

5.6.3. Asia Pacific

5.6.4. Latin America

5.6.5. Middle East & Africa

TOC Continued....

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/drug-eluting-stent-des-market-102612

Report Focus:

Extensive product offerings
Customer research services
Robust research methodology
Comprehensive reports
Latest technological developments
Value chain analysis
Potential Drug Eluting Stent Market opportunities
Growth dynamics
Quality assurance
Post-sales support
Regular report updates
Reasons to Purchase this Report:

Comprehensive analysis of the Drug Eluting Stent Market growth drivers, obstacles, opportunities, and other related challenges.
Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
Identifies market restraints and boosters.
Identifies all the possible segments present in the market to aid organizations in strategic business planning.

KEY QUESTIONS ANSWERED:

What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the Drug Eluting Stent Market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.